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Stepwise health surveillance for bronchial
irritability syndrome in workers at risk of
occupational respiratory disease
Wendel K Post, Katherine M Venables, David Ross, Paul Cullinan, Dick Heederik,
Alex Burdorf
Abstract
Objectives—Questionnaires, lung func-
tion tests, and peak flow measurements
are widely used in occupational health
care to screen for subjects with respira-
tory disease. However, the diagnostic per-
formance of these tests is often poor.
Application of these tests in a stepwise
manner would presumably result in a bet-
ter characterisation of subjects with respi-
ratory disease.
Methods—Cross sectional data from work-
ers exposed to acid anhydrides, to labora-
tory animals, and to flour dusts were used.
Sensitivity and specificity were calculated
from cross tables of diVerent (combina-
tions of) tests for bronchial hyperrespon-
siveness and bronchial irritability in the
past four weeks (BIS). From sensitivity
and specificity likelihood ratios were com-
puted and change in probability of BIS
was calculated.
Results—The prevalence of BIS was 7%,
7%, and 5%, respectively. In all groups
questionnaire data provided excellent
sensitivity but poor specificity, which was
inherent on the broad definition of symp-
toms. Adding the forced expiratory
volume in one second/forced vital capacity
(FEV1/FVC) ratio yields almost perfect
specificity, and peak expiratory flow (PEF)
variability is intermediate in populations in
which smoking induced or non-allergic
respiratory diseases predominates. In oc-
cupational groups in which asthma is a
problem, adding PEF measurements will
optimise sensitivity and specificity in de-
tection of BIS. The probability of BIS for
subjects with a negative combined test out-
come was lower than the probability before
testing. Subjects with a positive combined
test outcome had a probability of BIS after
the tests at least three times the probability
before.
Conclusions—Combined testing yields bet-
ter sensitivity and specificity. An advantage
of combined testing is an economy in the
eVort to screen for subjects with BIS.
Combined testing resulted inmore detailed
estimation of the probability of BIS.
(Occup Environ Med 1998;55:119–125)
Keywords: bronchial irritability syndrome; asthma;
COPD; occupational health surveillance; sensitivity;
specificity; disease probability
In occupational health care, a questionnaire on
respiratory symptoms—such as chronic cough,
production of phlegm, wheezing, chest tight-
ness or breathlessness, and spirometry, are the
most widely used tests in surveillance pro-
grammes for obstructive lung diseases such as
asthma and chronic obstructive pulmonary
disease (COPD). For instance, in the United
Kingdom, occupational physicians stated that
the basis of the diagnosis in patients with occu-
pational asthma reported to the surveillance of
work related and occupational respiratory
disease project (SWORD), included the history
in 96% of the cases, lung function tests in 62%,
serial peak flow in 56%, and serological
measurement of IgE or IgG in 18%. In 6% of
the cases bronchial challenge was carried out.1
Because several tests are regularly used for
detecting asthma a stepwise approach can be
devised.2 3 The stepwise combination of out-
comes of tests may improve detection of
subjects with disease. As there is no generally
accepted definition of asthma or COPD,
validation of a screening procedure comprising
various tests should be evaluated by compari-
son with a selected standard.
Althoughmeasurement of non-specific bron-
chial hyperresponsiveness (NSBHR) has
proved to be useful in the clinical assessment of
patients with asthma or in occupational
asthma, its usefulness in an epidemiological
setting or occupational health care is still
debatable.4 Presence of NSBHR is usually
regarded as the defining physiological charac-
teristic of asthma,5 6 but it is also associated
with other respiratory diseases, such as COPD
and bronchitis and with smoking.7 The
NSBHR is aVected by reduction in airway cali-
bre, which can be caused by several factors
such as smoking or respiratory disease. Studies
of NSBHR among smokers with and without
chronic bronchitis suggested that smoking,
chronic bronchitis, and NSBHR are related. In
particular, smokers with chronic bronchitis
often have levels of NSBHR greater than non-
smokers, but less than asthmatic patients. It
seems, therefore, of particular interest to the
occupational physician to measure bronchial
hyperresponsiveness to detect subjects with
asthma or other respiratory disease—such as
chronic bronchitis.
Disadvantages of using NSBHR as a gold
standard is the demand on resources (appara-
tus, qualified personnel, and costs) and safety
issues. Providing reasonable safety and strin-
gent measures the test is not dangerous. A
major disadvantage is that not all people with
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NSBHR report respiratory symptoms.8 9 In
epidemiological studies the combination of
symptoms and NSBHR has therefore been
recommended.4 10 11
In the current decision analysis study, we
used the presence of NSBHRmeasured by his-
tamine challenge testing in combination with
questions on bronchial irritability in the past
four weeks as the gold standard for the
bronchial irritability syndrome (BIS). We have
previously developed a nine item questionnaire
of bronchial irritability symptoms for asthma
epidemiology.12 Mortagy et al used bronchial
irritability symptoms in conjunction with a fall
of 20% or more in forced expiratory volume in
one second (FEV1) at a provocative concentra-
tion of <0.5 g/l histamine to describe BIS.
They found that the bronchial irritability
syndrome was closely associated with asthma,
but that BIS and asthma cannot be considered
synonymous, as most subjects with BIS had not
been diagnosed as asthmatic.13
We chose the most widely used tests in occu-
pational health care—that is, presence of respi-
ratory symptoms, spirometry, and serial peak
flow measurements as screening instruments.
Within occupational health care, a question-
naire survey, followed by spirometry seems the
most logical approach for sequential testing.
The performance of combined testing to iden-
tify subjects with respiratory disease was exam-
ined in three occupational groups with expo-
sures incriminated as causing respiratory
disease, especially asthma: workers exposed to
acid anhydrides, laboratory workers exposed to
rats or mice, and workers with occupational
exposure to flour dusts.
Methods
STUDY POPULATION
In the current study, data from studies among
workers with exposure to acid anhydrides,
laboratory animals, and flour dusts were
analysed. These were the retrospective cohort
study of 401 workers exposed to acid anhy-
drides; the baseline study of an ongoing follow
up study among 323 laboratory animal workers
who handled a variety of animals including
rats, and another 61 laboratory animal workers
who handled exclusively mice; and the baseline
study of an ongoing follow up study 344 work-
ers exposed to flour in bakeries and mills.
Survey methods are described in detail
elsewhere.14 15
MEDICAL EXAMINATION
All participants were asked to complete a ques-
tionnaire on age, sex, smoking history, occupa-
tional history, and respiratory symptoms.
Calibrated leak free Vitalograph spirometers
were used to record FEV1 and forced vital
capacity (FVC).Up to six readings of FVC and
FEV1 were recorded, with a minimum of three
readings until two reproducible curves were
achieved (FEV1 and FVC within 0.1 l). The
FEV1/FVC ratio was derived from the largest
FEV1 and FVC. For each subject a predicted
lung function variable was calculated with
regression equations of the European Respira-
tory Society.16 The residual lung function
(largest observed value−predicted value) was
used in all analyses.
Among the laboratory workers and the flour
workers, peak expiratory flow (PEF) records
were made with mini-Wright peak flow meters.
At each session, the highest value of three tests
was recorded, with the best of two readings
within 20 l/min of each other. Each subject was
asked to make four readings a day, a total of 28
PEF readings over seven days. The PEF
variability was calculated for each day with at
least two blows, as:
Amplitude % mean=100*(maximum−minimum)/
mean (%).
The mean value for all days was used in
analyses. Subjects with <21 readings over seven
days were excluded from analyses.
Bronchial responsiveness was measured by a
histamine inhalation test.17 If the baseline FEV1
was <1 l histamine challenge was not per-
formed.The dose provoking a 20% fall in FEV1
(PD20) was estimated by linear interpolation of
the last two log dose points, or by extrapolation
up to 8 µmol.
GOLD STANDARD FOR BIS
In the current study the definition of BIS incor-
porates information on the histamine challenge
test. Also, information was used about bronchial
irritability in the past four weeks. The questions
that were used were derived from a question-
naire of bronchial irritability symptoms.12 Sub-
jects with a PD20 <8 µmol histamine, and
reporting bronchial irritability in the past four
weeks were classified as having BIS.
DEFINITIONS
Table 1 summarises the definitions used in this
study. Subjects were classified as having symp-
Table 1 Definitions
Variable Criterion
NSBHR PD20 < 8 µmol histamine
BIS Bronchial irritability in past 4 weeks and NSBHR
Screening instruments:
Questionnaire
History of asthma Subjects who had asthma before first employment at current work site
History of bronchitis Subjects who ever had bronchitis or had ever been told that they had bronchitis
Symptom:
Chronic bronchitis symptoms Cough and/or phlegm on most days for 3 months/year
Upper respiratory symptoms Blocked, itchy, runny, or sneezing nose and/or itchy or runny eyes since first
employment at the site
Lower respiratory symptoms Chest tightness, diYculty breathing and/or wheezing or whistling since first
employment at the site
Spirometric lung function test FEV1/FVC residual < predicted—1.644*RSD (RSD=residual SD (6.5% for
women, 7.2% for men))16
Serial peak flow recordings Amplitude % mean peak flow > 10%
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toms if they reported at least one of the follow-
ing: cough or phlegm on most days for three
months a year, upper respiratory symptoms
that occurred since the start of work at the site,
or lower respiratory symptoms that occurred
since the start of work at the site. As
recommended by the American Thoracic
Society,18 the chosen cut oV for the FEV1/FVC
ratio was the lower five percentile calculated
with the formulas of the European Respiratory
Society.16 For the peak flow variability the cut
oVwas an amplitude %mean peak flow>10%,
which approximated the upper 95 percentile of
the distribution of peak flow variability in these
data stratified by occupational group and sex.
ANALYSIS
The relation between the screening instru-
ments and BIS was studied by cross tables,
from which sensitivity and specificity were cal-
culated; tests with continuous outcomes were
therefore dichotomised into normal and abnor-
mal results (table 1). With the sensitivity and
specificity of individual tests the likelihood
ratios of positive and negative tests were
computed. The likelihood ratio and probability
before testing were used to calculate the prob-
ability of BIS after the tests.19 Ideally, the prob-
ability before testing summarises all available
information at the time of testing. In the
current study, the prevalence of BIS within
each group was used as an estimate of the
probability of disease before testing. After test-
ing the probabilities are calculated for a
positive and a negative test outcome. The
resulting probability of BIS after one test is
used as the probability before the next step.19
The diagnostic performance of sequential test-
ing in each group was evaluated by both change
in probability of BIS and its sensitivity and
specificity.
All analyses were performed with statistical
analysis software.20
Results
NUMBER OF SUBJECTS
For 263 acid anhydride workers, 327 labora-
tory workers, and 237 workers with exposure to
flour dusts a complete data set was available
comprising subject characteristics, atopic sta-
tus, gold standard tests, and information on
symptoms and lung function.
In the group of workers exposed to acid
anhydrides no peak flow measurements were
performed. Among the laboratory workers
65% performed at least 21 peak flow record-
ings over seven days, among the flour workers
the response was lower, 49%. At the third step
of the decision tree for stepwise surveillance,
data of 256 laboratory workers and 166 flour
workers were analysed.
BIS
The prevalence of BIS was 7% among acid
anhydride workers, 7% among laboratory
workers, and 5% among flour workers. Among
the acid anhydride workers and the laboratory
workers another 29% of the workers and 39%
of the flour workers reported bronchial irrita-
bility in the past four weeks but had a normal
histamine challenge test. One per cent of the
acid anhydride workers, 3% of the laboratory
workers, and 2% of the flour workers had
NSBHR, but did not complain of the bronchial
irritability in the past four weeks.
Among the laboratory workers, significantly
more subjects without peak flowmeasurements
reported lower respiratory symptoms (41% v
27%), had a positive PD20 (17% v 7%), and
had a borderline significantly higher prevalence
of symptoms of bronchitis (13% v 7%, p=0.08)
and of bronchial irritability in the past four
weeks (40% v 30%, p=0.07). Consequently,
the prevalence of BIS was significantly higher
among laboratory workers without peak flow
measurements (12% v 4%). Among the flour
workers, subjects without peak flow measure-
ments had a higher prevalence of bronchial
irritability in the past four weeks (47% v 36%),
although this did not reach significance
(p=0.09).
RELATION BETWEEN SCREENING INSTRUMENTS
AND BIS
Table 2 gives the false positive rate (1-
specificity) and true positive rate (sensitivity) of
the screening instruments for detecting BIS.
All three screening instruments, questionnaire,
spirometric lung function test, and serial peak
flow measurements, were related to the pres-
Table 2 Screening instruments by occupational group and BIS
Acid anhydride workers (n=263; PD20
<8 µmol=21 (8%); B1 4 weeks=95
(36%))
Laboratory workers (n=327;PD20
<8 µmol=33 (10%);B1 4 weeks=118
(36%))
Flour workers (n=237;PD20 <8
µmol=17 (36%);B1 4 weeks=104
(44%))
no BIS
246 (93.5%)
n (%)
BIS
17 (6.5%)
n (%)
no BIS
304 (93.0%)
n (%)
BIS
23 (7.0%)
n (%)
no BIS
226 (95.4%)
n (%)
BIS
11 (4.6%)
n (%)
Questionnaire:
Chronic bronchitis symptoms 48 (20) 9 (53) 23 (8) 7 (30)* 41 (18) 5 (45)*
Upper respiratory symptoms 112 (46) 10 (59) 137 (45) 22 (96)* 103 (46) 9 (82)*
Lower respiratory symptoms 53 (22) 14 (82)* 82 (27) 22 (96)* 60 (27) 10 (91)*
> 1 symptom 131 (53) 15 (88) 169 (55) 23 (100)* 123 (54) 11 (100)*
Spirometric lung function test:
FVC residual < 5th percentile 5 (2) 1 (6) 6 (2) 0 (0) 7 (3) 0 (0)
FEV1 residual < 5th percentile 7 (3) 7 (41) 6 (2) 0 (0) 14 (6) 2 (18)*
FEV1/FVC residual < 5th
percentile
15 (6) 11 (65)* 10 (3) 3 (13)* 18 (8) 4 (36)*
Serial peak flow recordings†:
Amplitude % mean > 10% — — 20 (10) 4 (44)* 22 (19) 2 (50)*
*p <0.05 v subjects without BIS (continuous outcome t test, discrete outcomes ÷2, or Fisher’s exact test.
†For 211 laboratory animal workers including nine subjects with BIS, and 117 flour workers including four subjects with BIS.
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ence of BIS. If bronchial irritability in the past
four weeks was not included in the definition of
BIS, but NSBHR alone was used as a gold
standard instead, the sensitivity as well as the
specificity of symptoms versus NSBHR was
smaller, but diVerences were trivial (sensitivity
78%, 90%, and 80%, specificity 36%, 38%,
and 34% for acid anhydride workers, labora-
tory workers, and flour workers respectively).
SEQUENTIAL TESTING
Figures 1–3 show the decision trees for the dif-
ferent occupational groups. Beneath each tree,
the sensitivity and specificity of the tree after
each consecutive step is given.
The first step (questionnaire on respiratory
symptoms) in sequential testing showed that in
subjects without symptoms BIS was very
unlikely. In the second step, additional spirom-
etry in subjects with respiratory symptoms was
very specific, but had low sensitivity. In terms
of sensitivity and specificity, an abnormal
FEV1/FVC ratio was most accurate among the
acid anhydride workers. Due to the low
sensitivity of lung function testing among the
laboratory workers and flour workers with res-
piratory symptoms, the probability of BIS in
subjects with a negative spirometric lung func-
tion test dropped only marginally and was still
higher than the initial probability before
testing. In the third step of sequential testing,
among workers with a normal spirometric lung
function test, an abnormal peak flow variability
augmented the probability of BIS, although the
number of false positive results outnumbered
the number of true positive results by far. The
Figure 1 Stepwise health surveillance among workers with exposure to acid anhydrides. P=probability of BIS; n=number
of subjects with test result; positive test outcome=combined testing suggesting BIS; negative test outcome=combined testing
suggesting absence of BIS; true results=number of true positive results if combined test outcome is positive and number of
true negative results if combined test outcome is negative; false results=number of false positive results if combined test
outcome is positive and number of false negative results if combined test outcome is negative.
Combined
test result
Number of
true + false
results
9 + 13
118 + 6
115 + 2
FEV1/FVC < 5th percentile
FEV1/FVC > 5th percentile
Symptoms
Pretest
probability
(n =146, P = 0.10)
No symptoms
0.06
–
0.88
0.47
Sensitivity
Specificity
0.53
0.95
Step
1
Questionnaire
2
Questionnaire
+ spirometry
–
+
+
–
positive
negative
negative
0.39
0.04
0.02
Posttest
probability
Figure 2 Stepwise health surveillance among workers with exposure to laboratory animals. Explanations as for fig 1.
Combined
test result
Number of
true + false
results
1 + 0
1 + 5
3 + 14
93 + 4
135 + 0
amp/mean > 10%–
amp/mean > 10%–
FEV1/FVC
< 5th percentile
FEV1/FVC
> 5th percentile
(n = 9, P = 0.30)
(n = 183, P = 0.09)
Symptoms
Pretest
probability
(n =192, P = 0.10)
No symptoms
0.06
–
1.00
0.44
Sensitivity
Specificity
0.13
0.98
0.56
0.92
Step
1
Questionnaire
2
Questionnaire
+ spirometry
3
Questionnaire
+ spirometry
+ serial peak flow
–
+
amp/mean < 10%
amp/mean < 10%
–
+
+
+
+
–
positive
positive
positive
negative
negative
1
0.17
0.25
0.06
0.00
Posttest
probability
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probability of BIS dropped to the initial prob-
ability of BIS for subjects with normal peak
flow variability. In workers with an abnormal
spirometric lung function test, the probability
of BIS in laboratory animal workers and flour
workers showed contradictory results.
Discussion
The main goal of health surveillance pro-
grammes in occupational health care should be
to detect workers with disabling disease early in
its course, and ultimately, prevent progression
to more severe disease with its associated mor-
bidity and disability.2 Ideally, surveillance tests
must have good sensitivity to detect all people
with the disease under study. To avoid many
false positive results, high specificity is also of
importance. As screening tests are performed
on workers who have no clear symptoms or
findings of disease, the probability of disease
before testing is very low. Therefore, there will
be many undiseased workers who are candi-
dates for false positive results, and few diseased
workers. With relatively few truly diseased sub-
jects, the false positive rate strongly aVects the
interpretation of a positive result; the lower the
false positive rate of a test (or the higher the
specificity), the higher the probability of
disease after testing.
The aim of the current analyses was to
evaluate screening instruments currently used
in occupational health services on their useful-
ness to identify subjects with respiratory
diseases—such as asthma and chronic bronchi-
tis. The acid anhydride workers are probably
more aVected by chronic obstructive pulmo-
nary disease induced by smoking. Among
laboratory animal handlers asthma will pre-
sumably predominate, whereas among the
flour worker a mixture of COPD and asthma is
not unlikely. Although surveillance might be
preferred for work related or even occupational
respiratory disease in these occupational
groups, we choose to identify NSBHR with the
presence of BIS. We think that the first step in
surveillance in occupational groups is to detect
those subjects with disease, applying general
diagnostic tests. Occupational physicians
should be aware that identifying BIS in a work-
ing population does not mean that it is work
related. In a second step, subjects with
suspected disease should be tested with specific
diagnostic tools to establish the likelihood of a
causal relation with agents in the work
environment.
In the three study groups, several diagnostic
tests had been carried out, which could all be
used as either a gold standard test or as part of
the screening procedure. Other researchers
might have chosen another definition of gold
standard or other tests as screening instru-
ments, and we emphasise that the current
study is only one possible approach for surveil-
lance of respiratory disorders in occupational
health care.
We used a gold standard defined as a positive
histamine challenge test in subjects who
reported bronchial irritability in the preceding
four weeks—for example, wheeze and difficulty
in breathing in defined circumstances such as
sleep and exercise. Mortagy et al studied bron-
chial irritability symptoms in combination with
NSBHR, and named it the bronchial irritability
syndrome (BIS).13 They found that only 27%
of subjects with BIS had been diagnosed as
asthmatic by their general practitioners. Al-
most 8% had been diagnosed as having other
respiratory diseases. The current analysis gives
no further insight into the relation between BIS
and asthma or COPD. However, information
on medication for chest or breathing and
history of respiratory disease showed that BIS
cannot be regarded as a gold standard for
asthma alone, but that it can also be an indica-
tion of COPD.
We used a stepwise logical approach for sur-
veillance of workers’ health, anticipating a bet-
ter characterisation of BIS with the combina-
Figure 3 Stepwise health surveillance among workers with exposure to flour dusts. Explanations as for fig 1.
Combined
test result
Number of
true + false
results
1 + 4 
1 + 1
1 + 10
44 + 1
103 + 0
amp/mean > 10%–
amp/mean > 10%–
FEV1/FVC
< 5th percentile
FEV1/FVC
> 5th percentile
(n = 14, P = 0.34)
(n = 120, P = 0.08)
Symptoms
Pretest
probability
(n =134, P = 0.10)
No symptoms
0.06
–
1.00
0.46
Sensitivity
Specificity
0.36
0.96
0.75
0.91
Step
1
Questionnaire
2
Questionnaire
+ spirometry
3
Questionnaire
+ spirometry
+ serial peak flow
–
+
amp/mean < 10%
amp/mean < 10%
–
+
+
+
+
–
positive
positive
positive
negative
negative
0.25
0.57
0.18
0.05
0.00
Posttest
probability
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tion of diVerent tests than with the same tests
separately, as more information is used.
Administration of the tests to be considered
had to be feasible within occupational health
care; a questionnaire on respiratory symptoms,
spirometry, and serial peak flow measurements
were chosen as instruments for screening.
Despite diVerences between the three occu-
pational groups under study in age, smoking,
sex, and atopy, the prevalence of BIS was simi-
lar and reporting of respiratory symptoms gave
a surprisingly similar picture. The definition of
symptoms in the current study was very broad,
including chronic bronchitis-like symptoms
(chronic cough and phlegm), upper respiratory
symptoms (eye and nasal symptoms), and
lower respiratory symptoms (wheezing, chest
tightness, and diYculty breathing). The sensi-
tivity of reporting any of the respiratory symp-
toms was high, ranging between 88% and
100%, with a specificity around 46% in all
three occupational groups. This means that
almost all subjects with BIS were identified in
the first step of the tree, together with many
false positive subjects.
In earlier studies the FVC, FEV1, and FEV1/
FVC ratio have been found to be very specific
to detect respiratory obstructive disease (90%–
95%), but to have a low sensitivity (around
20%).21 22 More recently, validation of the
FEV1/FVC for bronchial hyperresponsiveness
yielded a sensitivity of 21%,with a specificity of
97%.23 In our study, a low FEV1/FVC was
more likely to appear in symptomatic subjects
with BIS, but except for the acid anhydride
workers, its sensitivity was very low. A probable
explanation of this diVerence is the older age
distribution of the acid anhydride workers, who
are possibly more aVected by chronic obstruc-
tive pulmonary diseases induced by smoking
than the other groups. In patients with COPD
there is a strong relation between baseline
forced expiratory volume and bronchial hyper-
responsiveness to methacholine or histamine.24
The flour workers were older than the
laboratory workers, and non-allergic mecha-
nisms in these groups have been suggested in
earlier cross sectional analysis of these two
cohorts, which showed diVerent associations
with symptoms and skin reactivity against
occupational allergens.15 This might explain
why FEV1/FVC was slightly better in classify-
ing subjects with BIS as abnormal among the
flour workers than among laboratory workers.
The accuracy of the peak flow measurements
can also be related to the studied population.
Among the laboratory workers subjects were at
risk of developing asthma more than COPD
and thus peak flowmeasurements yield a better
performance than spirometry.
As a result of the high specificity of
FEV1/FVC, combining presence of respiratory
symptoms and an abnormal FEV1/FVC test
resulted in a high specificity, and thus a drop in
the number of false positive results and a
higher probability of BIS if test results were
positive. On the other hand, a rise in specificity
can only occur at the expense of sensitivity,
and therefore the number of false negative
results increased. Because the specificity was
so much higher than the sensitivity, less precise
clinical information is required to confirm the
diagnosis of BIS if the FEV1/FVC is abnormal
than is needed to exclude the diagnosis if the
FEV1/FVC is normal. Therefore, especially
in subjects with respiratory symptoms and
normal lung function, further testing is
warranted.
We found that the laboratory workers
without peak flow measurements had a some-
what higher prevalence of BIS. Despite the
short recording period and low compliance
that might have caused selection bias, peak flow
recording seemed particularly worthwhile
among symptomatic workers with a normal
FEV1/FVC. In our analysis, it does not seem
necessary to do peak flow tests on those with
positive symptoms and abnormal spirometry to
further exclude or confirm the diagnosis of
BIS. However, the few subjects in this particu-
lar step of the tree, should be borne in mind.
Combination of respiratory symptoms,
spirometry, and peak flow variability to identify
abnormal subjects had a sensitivity of 56%
among laboratory workers and 75% among
flour workers, which compares favourably with
the sensitivity of peak flow measurements alone.
The corresponding specificity was >90% in
both cases.
Another advantage of combined testing is an
economy in the eVort to screen for subjects
with BIS. The use of a questionnaire is
relatively simple and cheap and reduces the
number of subjects who would have to perform
peak flow measurements. As fewer people per-
form peak flow measurements, more eVort can
be put into a higher compliance with serial
peak flow measurements. The moderate com-
pliance with peak flow measurements is a
disadvantage of this test for epidemiological
studies. Furthermore, a combination of respi-
ratory symptoms, spirometry, and serial peak
flow resulted in a more detailed estimation of
probabilities of BIS after testing.
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